87 related articles for article (PubMed ID: 25433983)
1. FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.
Jiang T; Gao G; Fan G; Li M; Zhou C
Lung Cancer; 2015 Jan; 87(1):1-7. PubMed ID: 25433983
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
Cihoric N; Savic S; Schneider S; Ackermann I; Bichsel-Naef M; Schmid RA; Lardinois D; Gugger M; Bubendorf L; Zlobec I; Tapia C
Br J Cancer; 2014 Jun; 110(12):2914-22. PubMed ID: 24853178
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor 1 amplification in laryngeal squamous cell carcinoma.
Monico J; Miller B; Rezeanu L; May W; Sullivan DC
PLoS One; 2018; 13(1):e0186185. PubMed ID: 29351293
[TBL] [Abstract][Full Text] [Related]
4. Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.
Malchers F; Nogova L; van Attekum MH; Maas L; Brägelmann J; Bartenhagen C; Girard L; Bosco G; Dahmen I; Michels S; Weeden CE; Scheel AH; Meder L; Golfmann K; Schuldt P; Siemanowski J; Rehker J; Merkelbach-Bruse S; Menon R; Gautschi O; Heuckmann JM; Brambilla E; Asselin-Labat ML; Persigehl T; Minna JD; Walczak H; Ullrich RT; Fischer M; Reinhardt HC; Wolf J; Büttner R; Peifer M; George J; Thomas RK
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37606995
[TBL] [Abstract][Full Text] [Related]
5. Association of fibroblast growth factor receptor 1 gene amplification with poor survival in patients with esophageal squamous cell carcinoma.
Wang D; Du L; Wang Z; Liu X; Qin Y; Wang Q; Yang Z; Yao Z; Shi M; Shang B; Jia Y; Chen H; Qiao L; Wang X; Xiao Z; Liu Z
Oncotarget; 2017 Oct; 8(51):88857-88869. PubMed ID: 29179482
[TBL] [Abstract][Full Text] [Related]
6. Genomic insights into the mechanisms of FGFR1 dependency in squamous cell lung cancer.
Mäkinen N; Meyerson M
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37909331
[TBL] [Abstract][Full Text] [Related]
7. Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity.
Wu D; Pang Y; Wilkerson MD; Wang D; Hammerman PS; Liu JS
Br J Cancer; 2013 Sep; 109(6):1599-608. PubMed ID: 24002593
[TBL] [Abstract][Full Text] [Related]
8. FGFR1 amplifications in squamous cell carcinomas of the lung: diagnostic and therapeutic implications.
Schildhaus HU; Nogova L; Wolf J; Buettner R
Transl Lung Cancer Res; 2013 Apr; 2(2):92-100. PubMed ID: 25806220
[TBL] [Abstract][Full Text] [Related]
9. High-resolution genomic configuration of
Hong SH; Kim TM
Transl Lung Cancer Res; 2024 Feb; 13(2):236-239. PubMed ID: 38496689
[No Abstract] [Full Text] [Related]
10. Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer.
Zhao D; Lu Y; Yang C; Zhou X; Xu Z
Tumour Biol; 2015 May; 36(5):3637-42. PubMed ID: 25566961
[TBL] [Abstract][Full Text] [Related]
11. The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.
Park JS; Lee JS; Kim EY; Jung JY; Kim SK; Chang J; Kim DJ; Lee CY; Jung I; Kim JH; Kim HR; Moon YW; Kim HS; Cho BC; Shim HS
Lung Cancer; 2015 Jun; 88(3):325-31. PubMed ID: 25819384
[TBL] [Abstract][Full Text] [Related]
12. [Advances on driver oncogenes of non-small cell lung cancer].
Zhao J; Xiong J
Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):42-7. PubMed ID: 25603872
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers.
Kim MY; Koh J; Kim S; Go H; Jeon YK; Chung DH
Lung Cancer; 2015 Apr; 88(1):24-33. PubMed ID: 25662388
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.
Udagawa H; Ishii G; Morise M; Umemura S; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Tsuboi M; Goto K; Ochiai A; Ohe Y
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1417-25. PubMed ID: 25573625
[TBL] [Abstract][Full Text] [Related]
15. Rationale for targeting fibroblast growth factor receptor signaling in breast cancer.
André F; Cortés J
Breast Cancer Res Treat; 2015 Feb; 150(1):1-8. PubMed ID: 25677745
[TBL] [Abstract][Full Text] [Related]
16. Molecular testing in lung cancer in the era of precision medicine.
Popper HH; Ryska A; Tímár J; Olszewski W
Transl Lung Cancer Res; 2014 Oct; 3(5):291-300. PubMed ID: 25806314
[TBL] [Abstract][Full Text] [Related]
17. SOCS3 blocks HIF-1α expression to inhibit proliferation and angiogenesis of human small cell lung cancer by downregulating activation of Akt, but not STAT3.
Wan J; Che Y; Kang N; Wu W
Mol Med Rep; 2015 Jul; 12(1):83-92. PubMed ID: 25695729
[TBL] [Abstract][Full Text] [Related]
18. Illuminating the molecular mechanisms of tyrosine kinase inhibitor resistance for the FGFR1 gatekeeper mutation: the Achilles' heel of targeted therapy.
Sohl CD; Ryan MR; Luo B; Frey KM; Anderson KS
ACS Chem Biol; 2015 May; 10(5):1319-29. PubMed ID: 25686244
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinoma.
Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Jung DH; Shin SK; Lee SK; Lee YC; Kim HR; Moon YW; Kim JH; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
Oncotarget; 2015 Feb; 6(4):2562-72. PubMed ID: 25537505
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
